Stock Buybacks (Quarterly) Chart

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2012. Start Trial.
Date Value
June 30, 2026 -0.0004M
March 31, 2026 -0.016M
December 31, 2025 -12.42M
September 30, 2025 -1.300M
June 30, 2025 -0.276M
March 31, 2025 -0.195M
December 31, 2024 -0.1496M
September 30, 2024 -0.7101M
June 30, 2024 -2.365M
March 31, 2024 -2.188M
December 31, 2023 -1.289M
September 30, 2023 -1.780M
June 30, 2023 -0.0925M
March 31, 2023 0.00
December 31, 2022 -0.7301M
September 30, 2022 -0.7517M
June 30, 2022 -0.2436M
March 31, 2022 -0.336M
December 31, 2021 -0.2563M
September 30, 2021 -0.6989M
June 30, 2021 -0.0828M
March 31, 2021 -0.413M
December 31, 2020 -182.32M
September 30, 2020 -191.80M
June 30, 2020 -75.87M
Date Value
March 31, 2020 -0.118M
December 31, 2019 -0.0238M
September 30, 2019 -22.03M
June 30, 2019 -15.65M
March 31, 2019 0.00
December 31, 2018 0.0025M
September 30, 2018 0.0206M
June 30, 2018 -0.0513M
March 31, 2018 -0.294M
December 31, 2017 -7.171M
September 30, 2017 0.00
June 30, 2017 0.00
March 31, 2017 0.00
December 31, 2016 0.0001M
September 30, 2016 0.00
June 30, 2016 -0.0001M
March 31, 2016 -0.006M
December 31, 2015 -38.37M
September 30, 2015 -0.0434M
June 30, 2015 -0.2903M
March 31, 2015 -27.90M
December 31, 2014 0.00
September 30, 2014 0.00
June 30, 2014 0.00
March 31, 2014 0.00

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. -10.49M
Emergent BioSolutions, Inc. 8.00M
Exelixis, Inc. 307.53M
Ionis Pharmaceuticals, Inc. -20.26M
United Therapeutics Corp. -126.30M